250 related articles for article (PubMed ID: 26148235)
21. Effects of MdmX on Mdm2-mediated downregulation of pRB.
Uchida C; Miwa S; Isobe T; Kitagawa K; Hattori T; Oda T; Yasuda H; Kitagawa M
FEBS Lett; 2006 Mar; 580(7):1753-8. PubMed ID: 16510145
[TBL] [Abstract][Full Text] [Related]
22. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
Li Y; Zhou Z; Chen C
Cell Death Differ; 2008 Dec; 15(12):1941-51. PubMed ID: 18806757
[TBL] [Abstract][Full Text] [Related]
23. p53 Ubiquitination and proteasomal degradation.
Love IM; Shi D; Grossman SR
Methods Mol Biol; 2013; 962():63-73. PubMed ID: 23150437
[TBL] [Abstract][Full Text] [Related]
24. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
[TBL] [Abstract][Full Text] [Related]
25. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
Lin J; Tang H; Jin X; Jia G; Hsieh JT
Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540
[TBL] [Abstract][Full Text] [Related]
26. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.
Qiu W; Wu J; Walsh EM; Zhang Y; Chen CY; Fujita J; Xiao ZX
Oncogene; 2008 Jul; 27(29):4034-43. PubMed ID: 18332869
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 Nef promotes ubiquitination and proteasomal degradation of p53 tumor suppressor protein by using E6AP.
Ali A; Farooqui SR; Rai J; Singh J; Kumar V; Mishra R; Banerjea AC
Biochem Biophys Res Commun; 2020 Sep; 529(4):1038-1044. PubMed ID: 32819562
[TBL] [Abstract][Full Text] [Related]
28. Heat shock protein gp96 decreases p53 stability by regulating Mdm2 E3 ligase activity in liver cancer.
Wu B; Chu X; Feng C; Hou J; Fan H; Liu N; Li C; Kong X; Ye X; Meng S
Cancer Lett; 2015 Apr; 359(2):325-34. PubMed ID: 25637791
[TBL] [Abstract][Full Text] [Related]
29. Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli-1 degradation via the ubiquitin-proteasome pathway.
Yao J; Xu T; Tian T; Fu X; Wang W; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
Oncol Rep; 2016 Feb; 35(2):1204-12. PubMed ID: 26718507
[TBL] [Abstract][Full Text] [Related]
30. Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein.
Abedini MR; Muller EJ; Bergeron R; Gray DA; Tsang BK
Oncogene; 2010 Jan; 29(1):11-25. PubMed ID: 19802016
[TBL] [Abstract][Full Text] [Related]
31. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
[TBL] [Abstract][Full Text] [Related]
32. Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradation.
Seo SK; Hwang CS; Choe TB; Hong SI; Yi JY; Hwang SG; Lee HG; Oh ST; Lee YH; Park IC
Oncotarget; 2015 Sep; 6(28):26528-40. PubMed ID: 25605253
[TBL] [Abstract][Full Text] [Related]
33. RNF2/Ring1b negatively regulates p53 expression in selective cancer cell types to promote tumor development.
Su WJ; Fang JS; Cheng F; Liu C; Zhou F; Zhang J
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1720-5. PubMed ID: 23319651
[TBL] [Abstract][Full Text] [Related]
34. Ret finger protein 2 enhances ionizing radiation-induced apoptosis via degradation of AKT and MDM2.
Joo HM; Kim JY; Jeong JB; Seong KM; Nam SY; Yang KH; Kim CS; Kim HS; Jeong M; An S; Jin YW
Eur J Cell Biol; 2011 May; 90(5):420-31. PubMed ID: 21333377
[TBL] [Abstract][Full Text] [Related]
35. Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells.
Sarkar S; Brautigan DL; Parsons SJ; Larner JM
Oncogene; 2014 Jan; 33(1):26-33. PubMed ID: 23246967
[TBL] [Abstract][Full Text] [Related]
36. RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer.
Yang H; Xue M; Su P; Zhou Y; Li X; Li Z; Xia Y; Zhang C; Fu M; Zheng X; Luo G; Wei T; Wang X; Ding Y; Zhu J; Zhuang T
J Exp Clin Cancer Res; 2022 Dec; 41(1):364. PubMed ID: 36581998
[TBL] [Abstract][Full Text] [Related]
37. CHIP-dependent p53 regulation occurs specifically during cellular senescence.
Sisoula C; Trachana V; Patterson C; Gonos ES
Free Radic Biol Med; 2011 Jan; 50(1):157-65. PubMed ID: 20974249
[TBL] [Abstract][Full Text] [Related]
38. Silencing of the SNARE protein NAPA sensitizes cancer cells to cisplatin by inducing ERK1/2 signaling, synoviolin ubiquitination and p53 accumulation.
Wu ZZ; Sun NK; Chien KY; Chao CC
Biochem Pharmacol; 2011 Dec; 82(11):1630-40. PubMed ID: 21903092
[TBL] [Abstract][Full Text] [Related]
39. BCAS3 exhibits oncogenic properties by promoting CRL4A-mediated ubiquitination of p53 in breast cancer.
Zhou Z; Qiu R; Liu W; Yang T; Li G; Huang W; Teng X; Yang Y; Yu H; Yang Y; Wang Y
Cell Prolif; 2021 Aug; 54(8):e13088. PubMed ID: 34240781
[TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y
Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
